Answers are grounded in this paper and cite their sources.
Colorectal cancer (CRC) is a commonly diagnosed cancer and is the third leading cause of cancer deaths around the world. A broad spectrum of therapeutic options are available currently for colon cancer treatment, however, these options lead to side effects and trauma. Thus, it needs to detect novel treatment approaches for colon cancer prevention. In connection, recently natural product research has been increased in the prevention of incidence and risk of colon cancer due to their minimal toxic side effects. In this review, the authors have focused on naringenin, a predominant flavonoid present in Citrus fruits, tomatoes, and other fruits and frequently used in the human diet. Several pharmacological properties have been reported for this bioactive ingredient through in vitro and in vivo preclinical studies, among them anticancer, antiviral, antimicrobial, anti-inflammatory, anti-diabetic, hepatoprotective, cardioprotective, antiproliferative, and antioxidant properties. The research information collected from literature reveals diet supplemented naringenin exhibited benefits to human health and reported protection against colorectal cancer through cellular activities modulation. In this review, the authors give detailed structure, sources, and biological properties of naringenin due to their efficient pharmacological profile and use in various ailments cure and finally described colon cancer, molecular pathways involved in colon cancer and the importance of naringenin in the prevention of colorectal cancer through their anticancer effects via modulation of cellular and molecular mechanisms. The impressive pharmacological profile of naringenin may be useful in the treatment of various diseases in the future and may act as a vital source for effective medicine development.
No takes yet. Share an insight, caveat, or question.
Sarojamma et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: